Fig. 1 · Structure
Documents & Downloads
β-1,4-Galactosyltransferase, neisseria meningitides
Beta-1,4-Galactosyltransferase
β-1,4-Galactosyltransferase from Neisseria meningitidis (LgtB) is an enzyme that catalyzes the transfer of galactose from UDP-galactose to N-acetylglucosamine, resulting in the formation of galactose beta-1,4-N-acetylglucosamine. This enzyme plays a critical role in glycoconjugate biosynthesis and is utilized in various biochemical studies to explore glycan structures and their implications in cellular processes. Its specific mechanism makes it a valuable tool for research in glycoprotein and glycolipid development.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 9054-94-8 |
| Applications | Beta-1,4-Galactosyltransferase |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.